help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vancheri, C.
Right arrow Articles by Mistretta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vancheri, C.
Right arrow Articles by Mistretta, A.

Am. J. Respir. Cell Mol. Biol., Vol 15, No. 4, 10 1996, 460-466.

Human lung fibroblasts inhibit tumor necrosis factor-alpha production by LPS-activated monocytes

C Vancheri, N Crimi, E Conte, MP Pistorio, C Mastruzzo, M Lamicela, A Messina and A Mistretta
Institute of Respiratory Diseases, University of Catania, Italy.

Mononuclear phagocytes are important regulators of normal immune, inflammatory, and fibrotic responses. These functions are mediated through the production of several cytokines, including tumor necrosis factor-alpha (TNF-alpha), which regulate the activity of inflammatory and tissue structural cells such as fibroblasts. It is increasingly evident that fibroblasts are also capable of releasing a number of cytokines and soluble factors that can, in turn, interact with monocytes and thereby modulate the inflammatory process. In this study we provide evidence that human lung fibroblasts, through the release of soluble factors such as prostaglandin E2 (PGE2), inhibit both TNF messenger ribonucleic acid (mRNA) accumulation and TNF-alpha protein release by lipopolysaccharide (LPS)-activated human peripheral blood monocytes (PBM). Reverse transcriptase-polymerase chain reaction (RT- PCR) results showed that fibroblast-conditioned medium (FCM) caused a 50% reduction of the TNF-alpha transcript accumulation in LPS- stimulated monocytes. Furthermore, FCM induced a significant decrease in the release of TNF-alpha by LPS-activated PBM. This effect was dependent on the concentration of the FCM and the number of fibroblasts producing it. The maximal effect was seen with monocytes cultured in 100% FCM produced by 2 x 10(6) fibroblasts. This indicated that one or possibly more soluble factors released by fibroblasts were responsible for the effect. Considering that exogenous PGE2 can inhibit TNF-alpha production by PBM, and that fibroblasts are a good source of PGE2, we determined the content of PGE2 in the FCM used in our experiments. We found a good correlation (r = 0.949) between the amount of PGE2 produced by fibroblasts and the degree of TNF-alpha inhibition exerted. In addition, the inhibitory effect of FCM was mimicked by the addition to PBM cultures of exogenous PGE2 in amounts similar to those spontaneously released by fibroblasts in FCM. All of these data suggest a molecular and cellular interaction between PBM and fibroblasts that could contribute to those modulatory mechanisms involved in the self- limitation of the fibrotic process.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Vancheri, C. Mastruzzo, V. Tomaselli, M. A. Sortino, L. D'Amico, G. Bellistri, M. P. Pistorio, E. T. Salinaro, F. Palermo, A. Mistretta, et al.
Normal Human Lung Fibroblasts Differently Modulate Interleukin-10 and Interleukin-12 Production by Monocytes . Implications for an Altered Immune Response in Pulmonary Chronic Inflammation
Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 592 - 599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Vancheri, M. A. Sortino, V. Tomaselli, C. Mastruzzo, F. Condorelli, G. Bellistrí, M. P. Pistorio, P. L. Canonico, and N. Crimi
Different Expression of TNF-alpha Receptors and Prostaglandin E2 Production in Normal and Fibrotic Lung Fibroblasts . Potential Implications for the Evolution of the Inflammatory Process
Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 628 - 634.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. E. WELTY-WOLF, M. S. CARRAWAY, Y.-C. T. HUANG, S. G. SIMONSON, S. P. KANTROW, and C. A. PIANTADOSI
Bacterial Priming Increases Lung Injury in Gram-negative Sepsis
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 610 - 619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1996 American Thoracic Society.